Home
Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Teva Inks $100m+ Deal To Settle West Virginia Opioid Claims
Israeli Company ‘Continues To Actively Negotiate A National Settlement’
May 26 2022
•
By
Dean Rudge
Teva admits no wrongdoing under the settlement • Source: Shutterstock
(Alamy Stock Photo)
More from Legal & IP
More from Generics Bulletin
